# Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation

> **NCT07537894** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 100 (estimated)

## Conditions studied

- Abortion
- Stillbirth
- PTSD (Childbirth-Related)
- Grief (Traumatic Grief and Existential Grief)

## Interventions

- **DRUG:** Dexmedetomidine (IV) 0.5 mcg/kg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07537894
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537894, "Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*